Early Clinical Development / Phase IIa
An experienced partner gets you results as you introduce your compound in humans and move to proof of concept.
Study delays and missed recruitment timelines are far too common. Your main considerations are quality, time and cost. By partnering with Covance, you can rest assured that your drug will stay on track toward the next development milestone. Our processes are specifically designed for early clinical studies. In fact, we have locked over 1,000 databases and met our healthy volunteer and patient enrollments over 90% in the past 5 years.